MarketInOut Stock Screener Log In | Sign Up
 

Braveheart Bio Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 10/23/2026
Braveheart Bio Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization1,893.52 mln
Float2.20 mln
Earnings Date11/12/2026

1-Year Forecast

45.25
Transformational upside

Relative Strength

92 / 100
Top performer

Debt / Equity

0.01
Debt-free

ROE

-30.95
Deeply negative

ROA

-28.03
Deeply negative

Business Description

Braveheart Bio Inc. is a San Francisco-based company founded in 2024 that works to create new treatments for people living with heart conditions. Its main focus is on a pill-form medicine designed to address two forms of a heart muscle disorder that can make it harder for the heart to pump blood properly. The company is currently in the clinical testing phase of development.

Key Fundamentals

EPS-6.08
ROE-30.95
ROIC-841
ROA-28.03
EBITDA, mln-29.26
EV / EBITDA-65.67
EV / EBIT-65.66

Quote Details

Last 21.44
Change -0.04 (-0.19%)
Open 21.45
Volume 118,834
Turnover 2,547,801
Average Volume 416,329

Financial Ratios

Current Ratio13.63
Debt / Equity0.01

Financial Strength

1-Year Target Price45.25
Short Ratio6.92

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 14.59% 97 / 100   
1 Month -8.26% 33 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Blog